• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tolerance to factor VIII inhibitors in hemophilia A patients: a French twist.

作者信息

Pascual V, Capra J D

出版信息

J Clin Invest. 1996 Mar 15;97(6):1357-8. doi: 10.1172/JCI118553.

DOI:10.1172/JCI118553
PMID:8617864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC507191/
Abstract
摘要

相似文献

1
Tolerance to factor VIII inhibitors in hemophilia A patients: a French twist.甲型血友病患者对凝血因子 VIII 抑制剂的耐受性：一种法国式转变。
J Clin Invest. 1996 Mar 15;97(6):1357-8. doi: 10.1172/JCI118553.
2
Prevalence of factor VIII inhibitors in patients with hemophilia A in Brazil.
Thromb Haemost. 1999 Mar;81(3):475-6.
3
[Poly-electrolyte fractionated porcine factor VIII in the treatment of hemophilia A].
Orv Hetil. 1993 Dec 26;134(52):2873-5.
4
Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors.在高反应性抑制物的甲型血友病患者中，使用含有血管性血友病因子的高纯度血浆源性凝血因子VIII诱导免疫耐受。
Haematologica. 2005 Sep;90(9):1288-90.
5
Treatment of patients with hemophilia A and inhibitors to factor FVIII with cimetidine.
Arch Med Res. 1996 Spring;27(1):15-8.
6
Disappearance of FVIII inhibitors in a severe hemophilia A neonate after steroid treatment correlated with a cytokine shift toward a T-helper 2 pattern.
Haematologica. 2000 Oct;85(10):1114-5.
7
Inhibitor development in a multitransfused patient with severe haemophilia A.
Thromb Haemost. 1999 Jul;82(1):151-2.
8
[Determination of coagulation factor VIII inhibitors].
Z Gesamte Inn Med. 1980 Apr 15;35(8):330-6.
9
[Inhibitors (antibodies) directed against factor VIII in hemophilia A (author's transl)].
Ther Umsch. 1979 Apr;36(4):326-9.
10
Is a change of factor VIII product a risk factor for the development of a factor VIII inhibitor?
Thromb Haemost. 1999 May;81(5):852.

本文引用的文献

1
Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A.血友病A患者脱敏后针对VIII因子抑制剂的中和性抗独特型抗体
J Clin Invest. 1996 Mar 15;97(6):1382-8. doi: 10.1172/JCI118558.
2
Treatment of factor VIII inhibitors: products and strategies.
Semin Thromb Hemost. 1993;19(1):13-24. doi: 10.1055/s-2007-994002.
3
Treatment of patients with factor VIII and IX inhibitors.伴有凝血因子VIII和IX抑制剂的患者的治疗。
Thromb Haemost. 1993 Jul 1;70(1):56-9.
4
Immune tolerance in hemophilia-principal results from the International Registry. Report of the factor VIII and IX Subcommittee.血友病中的免疫耐受——国际注册研究的主要结果。凝血因子VIII和IX小组委员会报告。
Thromb Haemost. 1994 Jul;72(1):155-8.
5
Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin.大剂量静脉注射丙种球蛋白对针对凝血因子VIII（抗血友病因子）自身抗体的抗独特型抑制作用。
Lancet. 1984 Oct 6;2(8406):765-8. doi: 10.1016/s0140-6736(84)90701-3.
6
Acquired circulating anticoagulants in hemophilia A.
N Engl J Med. 1969 Oct 16;281(16):866-73. doi: 10.1056/NEJM196910162811603.
7
Incidence of inhibitors in patients with severe and moderate hemophilia A treated with factor VIII concentrates.
Am J Hematol. 1987 Mar;24(3):241-5. doi: 10.1002/ajh.2830240303.
8
Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies.从抗VIII:C（抗血友病因子）自身免疫性疾病中恢复取决于针对抗VIII:C自身抗体产生抗独特型抗体。
Proc Natl Acad Sci U S A. 1987 Feb;84(3):828-31. doi: 10.1073/pnas.84.3.828.
9
Identification of six functional clotting factor VIII:C epitopes by analysis of cross-reactive public idiotypes in murine monoclonal VIII:C inhibitors.通过分析鼠单克隆VIII:C抑制剂中的交叉反应性公共独特型鉴定六种功能性凝血因子VIII:C表位
Thromb Res. 1987 Mar 1;45(5):527-37. doi: 10.1016/0049-3848(87)90315-x.
10
Characterization of four monoclonal antibodies to factor VIII coagulant protein and their use in immunopurification of factor VIII.四种针对凝血因子VIII的单克隆抗体的特性及其在凝血因子VIII免疫纯化中的应用。
Thromb Haemost. 1986 Dec 15;56(3):271-6.